ClinConnect ClinConnect Logo
Search / Trial NCT06697925

Evaluating the Durability of Closure for Venous Leg Ulcers

Launched by KERECIS LTD. · Nov 18, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how long the closure of venous leg ulcers lasts after treatment. Venous leg ulcers are painful sores that can occur on the legs due to problems with blood circulation. The study will focus on patients who previously participated in the THOR trial and had their ulcers completely healed by the end of that study, which lasted 12 weeks.

To join this trial, participants need to be between the ages of 65 and 74 and must have successfully healed their ulcers in the THOR trial. If you meet these criteria, you could help researchers understand how long the benefits of the treatment last. If you take part, you can expect regular assessments to monitor the condition of your healed ulcer over time. This information will be important for improving future treatments for venous leg ulcers.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Subjects must have participated in the THOR trial and achieved complete closure by the 12-week endpoint.
  • Exclusion Criteria:
  • 1. Subjects who did not participate in the THOR trial. 2. Subjects who participated in the THOR trial and did not achieve complete closure.

About Kerecis Ltd.

Kerecis Ltd. is a pioneering biotechnology company focused on developing regenerative medicine solutions through the use of fish skin as a biologic alternative for wound healing and tissue regeneration. Leveraging advanced scientific research and innovative technology, Kerecis aims to address unmet medical needs in the treatment of chronic wounds, surgical wounds, and soft tissue reconstruction. The company's commitment to enhancing patient outcomes is reflected in its robust clinical trial programs, which are designed to validate the safety and efficacy of its products. By harnessing the natural properties of fish skin, Kerecis Ltd. is at the forefront of transforming wound care and improving the quality of life for patients worldwide.

Locations

Monroeville, Pennsylvania, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported